Carbapenems: Opening Pandora's Box
- 25 July 2020
- journal article
- letter
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 72 (11), 2066-2067
- https://doi.org/10.1093/cid/ciaa1075
Abstract
Sho Nishimura, MD; Are carbapenems the evil empire?, Clinical Infectious Diseases, , ciaa1075, https://doi.org/10.1093/cid/ciaa1075This publication has 4 references indexed in Scilit:
- Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective StudyClinical Infectious Diseases, 2019
- Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant RecipientsClinical Infectious Diseases, 2018
- Quantitative Contributions of Target Alteration and Decreased Drug Accumulation to Pseudomonas aeruginosa Fluoroquinolone ResistanceAntimicrobial Agents and Chemotherapy, 2013
- Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?Clinical Infectious Diseases, 2002